Cladribine manufacturers and suppliers in india

Cladribine

Properties

Melting point:: 181-185 °C(lit.)

alpha: D25 -18.8° (c = 1 in DMF)

Boiling point:: 547.6±60.0 °C(Predicted)

Density: 2.03±0.1 g/cm3(Predicted)

storage temp.: -20°C

solubility: Slightly soluble in water, soluble in dimethyl sulfoxide, slightly soluble in methanol, practically insoluble in acetonitrile. It shows polymorphism (5.9).

pka: 13.75±0.60(Predicted)

form: White solid

color: White to Pale Yellow

λmax: 265nm(EtOH aq.)(lit.)

Merck: 14,2337

Stability:: Store in Freezer

InChIKey: PTOAARAWEBMLNO-HSUXUTPPSA-N

Safety Information

Symbol(GHS): GHS06,GHS08

Signal word: Danger

Hazard statements: H301-H341-H361fd-H372

Precautionary statements: P201-P202-P260-P264-P270-P301+P310

Hazard Codes: T

Risk Statements: 36/37/38-23/24/25

Safety Statements: 26-37/39-45-36-22

RIDADR: UN 2811 6.1 / PGIII

WGK Germany: 3

RTECS: AU7357560

HS Code: 29349990

Toxicity: LD50 intraperitoneal in mouse: 150mg/kg

Use

Cladribine, an adenosine deaminase inhibitor, was introduced in the United States as a single intravenous treatment for hairy cell leukemia. The incorporation of a chlorine atom at the 2-position of deoxyadenosine renders cladribine more resistant to enzymatic attack by adenosine deaminase, resulting in a more prolonged cytotoxic effect. Cladribine efficiently crosses lymphocyte and monocyte cell membranes and is metabolized in cells to the biologically active triphosphate, which inhibits DNA synthesis. While most antineoplastic drugs are active primarily against dividing cells, cladribine destroys both resting and proliferating cells. Its potential uses in the treatment of autoimmune hemolytic anemia, multiple sclerosis, chronic lymphocytic leukemia and various lymphomas have also been evaluated.